Results 211 to 220 of about 54,330 (287)

Real-world comparative effectiveness of Bruton tyrosine kinase inhibitors in relapsed/refractory mantle cell lymphoma. [PDF]

Blood Adv
Phillips T, Di M, Miller TA, Wang J, Pierre A, Maglinte GA, Seymour EK, Wang Y.   +7 more
europepmc   +1 more source

Molecular Monitoring after Autologous Stem Cell Transplantation and Preemptive Rituximab Treatment of Molecular Relapse; Results from the Nordic Mantle Cell Lymphoma Studies (MCL2 and MCL3) with Median Follow-Up of 8.5 Years

, 2016
Arne Kolstad, Lone Bredo Pedersen, Christian Winther Eskelund, Simon Husby, Kirsten Grønbæk, Mats Jerkeman, Anna Laurell, Riikka Räty, Erkki Elonen, Niels Smedegaard Andersen, Peter de Nully Brown, Eva Kimby, Hans Bentzen, Christer Sundström, Mats Ehinger, Marja‐Liisa Karjalainen‐Lindsberg, Jan Delabie, Elisabeth Ralfkiær, Unn‐Merete Fagerli, Herman Nilsson‐Ehle, Grete F. Lauritzsen, Outi Kuittinen, Carsten Utoft Niemann, Christian H. Geisler   +23 more
openalex   +1 more source

PRDM1 expression levels in marginal zone lymphoma and lymphoplasmacytic lymphoma [PDF]

, 2017
Hassan, Anjum, Hussaini, Mohammad, Mirza, Abu-Sayeef, Pfeifer, John, Yeung, Cecilia, Zhu, Xiaopei   +5 more
core   +1 more source

Benefit of rituximab maintenance after first-line bendamustine-rituximab in patients with mantle cell lymphoma. [PDF]

Blood Adv
Wang Y, Larson MC, Hwang SR, Villa D, Kugathasan L, Kumar A, Joseph A, Brooks TR, Hill BT, Bond DA, Maddocks KJ, Nizamuddin IA, Kahl BS, Danilov A, Argao C, Ruan J, Ryan CE, Merryman RW, Grover NS, Khan NB, Ouchveridze E, Tun AM, Ayyappan S, Mou E, Pongas GN, Lossos IS, Harris ZI, Munoz JL, Young P, Portell CA, Baidoun F, Alhaj Moustafa M, Reagan PM, Banaszak LG, Pophali PA, Velayati A, Greenwell IB, Gerber D, Jain P, Wang ML, Narkhede MS, Mehta A, Stack AC, Messmer MR, Bhansali RS, Barta SK, Moyo TK, Ghosh N, Kamdar MK, Anna J, Stanisic AV, Karmali R, Maurer MJ, Cerhan JR, Cohen JB, Martin P.   +55 more
europepmc   +1 more source

Epidemiology, treatment patterns, and survival outcomes of patients with mantle cell lymphoma in Germany: a retrospective analysis of administrative claims data. [PDF]

Ann Hematol
Friedel H, Hennies N, Zschocke J, Hosseini SK, Bölz S, Bocuk D, Wilhelm S, Zaba O, Buske C.   +8 more
europepmc   +1 more source

Multiple skin tumors in a patient treated with orelabrutinib for mantle-cell lymphoma: Case report. [PDF]

Medicine (Baltimore)
Fu X, Zhang Y, Zeng L, Zhang Q, Fu X.
europepmc   +1 more source

Phase 2 study of relmacabtagene autoleucel (CD19 CAR-T) for relapsed/refractory mantle cell lymphoma in Chinese adults. [PDF]

Blood Adv
Xie Y, Zhou KS, Li LF, Liang AB, Mei H, Zou DH, Li WY, Jin J, Jin ZM, Jing HM, Yang HY, Chen T, Huang HQ, He PC, Cao JN, Xia Z, Gu YE, Zang YB, Zhou ZS, Tian ZZ, Zhu J, Song YQ.   +21 more
europepmc   +1 more source

Tumor evolution and immune microenvironment dynamics in primary and relapsed mantle cell lymphoma

Hui Wan, Weicheng Ren, Ming‐Yu Yang, Man Nie, Agata M. Wasik, Likun Du, Leire de Campos‐Mata, Rui Sun, Zhiliang Bai, Archibald Enninful, Yating Wang, Mattias Berglund, Rose‐Marie Amini, Xiaobo Li, Chunli Yang, Xiaofei Ye, Zhi-Zhang Yang, Stephen M. Ansell, Dongbing Liu, Mirjam van der Burg, Rong Fan, Kui Wu, Birgitta Sander, Qiang Pan‐Hammarström   +23 more
openalex   +1 more source

Clinical characteristics and prognostic features of patients with blastoid and pleomorphic variant mantle cell lymphoma: a real-world study in China. [PDF]

Ann Hematol
Huang Y, Zhang X, Lv Y, Wei J, Ye X, Zhang X, Yang C, Zhu Y, Wang J, Xu G, Yang M, Meng H, Xie W, Jin J, Tong H, Yu W.   +15 more
europepmc   +1 more source

Multiple relapses of mantle cell lymphoma as different extranodal lesions: A case report. [PDF]

Med Int (Lond)
Manabe M, Aohara D, Mukai D, Nanno S, Koh KR.   +4 more
europepmc   +1 more source